Evidence from genetic association studies is accumulating rapidly. Field synopses have recently arisen as an unbiased way of systematically synthesizing this evidence. We performed a systematic review and appraisal of published field synopses in genetic epidemiology and assessed their main findings and methodological characteristics. We identified 61 eligible field synopses, published between January 1, 2007, and October 31, 2013, on 52 outcomes reporting 734 significant associations at the P < 0.05 level. The median odds ratio for these associations was 1.25 (interquartile range, 1.15-1.43). Egger's test was the most common method (n = 30 synopses) of assessing publication bias. Only 12 synopses (20%) used the Venice criteria to evaluate the epidemiologic credibility of their findings (n = 449 variants). Eleven synopses (18%) were accompanied by an online database that has been regularly updated. These synopses received more citations (P = 0.01) and needed a larger research team (P = 0.02) than synopses without an online database. Overall, field synopses are becoming a valuable tool for the identification of common genetic variants, especially when researchers follow relevant methodological guidelines. Our work provides a summary of the current status of the field synopses published to date and may help interested readers efficiently identify the online resources containing the relevant genetic evidence.
The number of genetic association studies for complex traits has increased exponentially in the last several years (1, 2) . As of November 2013, the Human Genome Epidemiology (HuGE) Navigator database (3) had cataloged more than 85,000 articles pertaining to both candidate gene studies and genome-wide association studies (GWAS). Despite their large number, the majority of the proposed candidate gene associations were not replicated in subsequent studies as a result of limited statistical power, as well as selective reporting and other biases (4) . Moreover, the low prior probabilities for large numbers of comparisons among all candidate gene studies and in GWAS create the risk of false-positive findings, which has led to the adoption of stringent significance thresholds (5) . A scientific enterprise with so many false-positive findings can lose credibility or impede progress in research and translation (6) .
Knowledge synthesis and integration of findings from candidate gene studies and GWAS came to be regarded as essential, especially after the recommendations of the Human Genome Epidemiology Network (HuGENet) were published (7, 8) . Although similar approaches may have existed before, they became more apparent and standardized after 2007, when the first field synopses were published (9) (10) (11) (12) . Field synopses constitute a snapshot of the current state of knowledge on genetic associations in a particular field of research defined by a disease or trait (7) and provide a summary of the cumulative evidence on the genetic etiology of complex diseases and normal traits. Most importantly, one of their main aspects, according to the proposed framework, is the evaluation of the epidemiologic credibility of their findings using various approaches.
To date, several field synopses on various phenotypes have been published (10, 13, 14) . However, to the best of our knowledge, no systematic overview of these studies has been performed. We conducted a systematic appraisal of the published field synopses, and here we present the results, as well as the reported findings and statistical and methodological approaches used in the eligible articles.
METHODS

Search strategy
We searched PubMed (US National Library of Medicine, Bethesda, Maryland) for field synopses pertaining to genetic associations with a specific disease or trait that had been published between January 1, 2007, and October 31, 2013 . We used the algorithm ("systematic review" OR meta-analysis OR "field synopsis" OR "umbrella review") AND (gene OR genetic* OR polymorphism*). Following the HuGENet recommendations (7), we considered 2007 to be the year in which the first synopsis was published (10) . Additionally, to ensure that we included all potentially eligible synopses, we complemented our PubMed search by searching HuGE Navigator (http://www.hugenavigator.net/), a regularly updated database focusing exclusively on genetic association studies and meta-analyses thereof (3), using the term "field synopsis."
Eligibility criteria
Eligible articles were considered on the basis of the definition adopted by Khoury et al. (7) , which describes a field synopsis as a regularly updated snapshot of the current state of knowledge about genetic associations and common diseases. Ideally, a field synopsis should be freely available, should use online databases, should use objective and transparent criteria for grading the credibility of cumulative evidence, and should summarize and update the information in peer-reviewed articles on a regular basis (7) . We considered as study units all field synopses that had provided a systematic review of genetic associations between a disease or normal trait and variants in any gene and had additionally synthesized the available data using meta-analytical techniques. We excluded reports that did not systematically review the literature; that a priori restricted their search to specific genes and/or polymorphisms; that did not pertain to DNA polymorphisms (e.g., RNA sequence); that focused on pharmacogenetics; that were limited to the presentation of technical characteristics of published databases of genetic associations; that focused exclusively on specific gene families or on multiple variants of a specific gene; or that appraised already published meta-analyses. Two investigators (L.B., V.D.) independently screened and identified eligible synopses. Disagreements were resolved by consensus after discussions with the other 2 investigators.
Data extraction
The data were recorded from the main reports and from the supplementary material when needed. We extracted information on all nonoverlapping nominally significant associations reported by the authors of the eligible papers in main analyses and subgroup analyses carried out in various ethnic groups. When more than 1 genetic model had been used for the analysis, we captured the significant associations from the most powerful model, using the following order: per-allele, additive, dominant, recessive, and other models. When a significant association was available in main and subgroup analyses, we extracted the data corresponding to the main analyses. If a significant association was present in multiple subgroup analyses but not in the main analysis, we included the association from the analysis with the greatest statistical power (largest sample size). When an association was reported as significant under both fixed-effects and random-effects meta-analysis models, we extracted the effect sizes corresponding to the random-effects model for associations with high heterogeneity and to the fixed-effects model for associations with low heterogeneity, as specified by the authors of the synopses.
From each paper we extracted information on the first author, journal and year of publication, outcome, number of authors, main and subgroup analyses performed, number of eligible studies, total number of variants identified, number of polymorphisms claimed to be statistically significant, effect estimates and measures of uncertainty thereof (standard errors or confidence intervals), total sample size, and total number of data sets per significant association used for metaanalysis. We also recorded the criteria for performing metaanalysis, as well as the methods used (i.e., fixed-effects, random-effects, other). Additionally, we recorded the methods used for the assessment of between-study heterogeneity, small-study effects, publication bias, and/or other biases; the epidemiologic credibility of the identified associations (15); and adjustments for multiple comparisons (16) . We also recorded whether evaluation of Hardy-Weinberg equilibrium had been performed; the threshold of statistical significance used by the authors to deem an identified association significant; the sensitivity analyses performed; and whether any GWAS had been included. We assumed that the significance threshold was set at 0.05 if the authors did not specify otherwise.
We accessed the online "Catalog of Published GWAS" (http://www.genome.gov/gwastudies/) (17) to record whether there had been any published GWAS pertaining to the same outcomes as those in field synopses by the ending date of the synopses' literature search and to determine whether the synopses' authors had included all available GWAS data.
Two investigators (L.B., V.D.) independently extracted the data. Consensus was reached in cases of disagreement among the authors.
Data analysis
We calculated the median numbers (and their interquartile ranges) of nominally significant variants, eligible studies, data sets, authors, and citations. We also calculated the median effect sizes (and their corresponding interquartile ranges) of all significant associations for binary outcomes. We accepted the threshold used by the field synopses' authors to claim statistical significance. We converted the effect size so as to always reflect the risk allele for disease-related traits. We also calculated descriptive statistics for any sensitivity and subgroup analyses performed, and we summarized the methods and criteria used for meta-analysis and for assessment of publication bias/small-study effects. Finally, we estimated the number and percentage of associations that survived after the application of a more stringent statistical significance threshold.
Whenever the published reports mentioned an accompanying online database, we accessed the website, verified the database's existence, and assessed its frequency of data updates and format. We checked whether the databases had been updated at least once in the subsequent 24 months after their creation and recorded the date of their last update.
On December 28, 2013, we accessed ISI Web of Science (Thomson Reuters, New York, New York) to record the latest impact factor of the journals in which the field synopses had been published and the number of citations each field synopsis had received since its publication. We assessed whether the existence of a database affected the number of citations received and the target journal (based on the journal impact factor), using the Wilcoxon rank-sum test. For this analysis, we excluded journals that are not indexed in ISI Web of Science. We examined whether the association between the number of citations and the existence of a database was altered when we adjusted for the number of months since publication, performing a generalized linear model analysis with the number of citations as the dependent variable and the number of months since publication and the existence of a database as the independent variables. For recently published field synopses not yet indexed in ISI Web of Science, we performed a main analysis assuming that the number of citations these field synopses had received and the number of months since publication were both equal to zero and a sensitivity analysis excluding these synopses. Furthermore, we assessed whether the number of authors was higher in field synopses that were accompanied by an online database, using the Wilcoxon rank-sum test. We also examined the association between the existence of a database and the receipt of funding for conducting the synopsis, using Fisher's exact test. Additionally, to explore any potential factors influencing the existence of an online database, we performed a logistic regression analysis with the existence of a database as the dependent variable and the number of authors and the existence of funding as independent variables. Statistical analyses were performed in STATA, version 12.0 (StataCorp LP, College Station, Texas). All P values presented are 2-tailed.
RESULTS
Eligible field synopses
Our literature search yielded 9,221 studies, of which 61 studies met the inclusion criteria, as shown in Figure 1 . The eligible synopses were published between January 1, 2007, and October 31, 2013 . These synopses evaluated genetic risk factors for 52 outcomes (Table 1) . For 44 outcomes, there was only 1 field synopsis; for 1 outcome (ischemic stroke), there were 5 field synopses; for another outcome (intracranial aneurysms), there were 3 synopses; and for each of the remaining 6 outcomes (chronic lymphocytic leukemia, chronic obstructive pulmonary disease, colorectal cancer, meningococcal disease, preeclampsia, and subarachnoid hemorrhage), there were 2 synopses.
Characteristics of published field synopses
Of the 61 eligible synopses, 58 pertained to binary outcomes and used the odds ratio as the effect-size metric; 1 synopsis (18) pertained to a continuous outcome and used standardized mean differences; and 2 synopses (19, 20) included both binary and continuous outcomes. Of the 58 synopses with binary outcomes, 55 used an α level of 0.05 and estimated 95% confidence intervals, 2 synopses (21, 22) used an α level of 0.01 and estimated 99% confidence intervals, and 1 synopsis (23) used an α level of 0.05 and estimated 99% confidence intervals. The median number of eligible studies across the included synopses was 68 (interquartile range (IQR), 32-143). In total, 734 associations were nominally significant based on the thresholds used by the authors of the synopses. Eighty-one associations, from 5 field synopses, were subjected to a more stringent threshold set by their authors using the Bonferroni correction, and 68 (84%) of them remained significant after this correction.
The median number of nominally significant associations in each synopsis was 4 (IQR, 1-8), whereas the median number of data sets used for the meta-analyses of the 734 significant associations was 5 (IQR, [3] [4] [5] [6] [7] [8] [9] [10] [11] . The median odds ratio for all nominally significant variants was 1.25 (IQR, 1.15-1.43). GWAS were available at the time of completion of the literature search for 22 synopses, and 7 of them included these GWAS data in their analyses. These synopses pertained to bipolar disorder (24) , colorectal cancer (25, 26) , cutaneous melanoma (27) , intracranial aneurysm (28), Parkinson's disease (14) , and rheumatoid arthritis (29) .
The decision on whether to conduct a meta-analysis (Table 2) was based on at least 1 of the following criteria: 1) the number of data sets available per variant (n = 30); 2) the number of subjects per polymorphism (n = 4); and 3) the minor allele frequency in healthy controls (n = 1). Three synopses used only fixed-effects models for synthesis of the available data, 24 synopses used only random-effects models, 33 synopses used both random-effects and fixed-effects models, and the authors of 1 synopsis did not report the meta-analysis method applied ( Table 2 ). The most common criterion for performing a meta-analysis was the presence of at least 3 independent data sets per variant (n = 22), while 30 synopses did not apply any criteria for conducting a metaanalysis. Fifty-six synopses assessed heterogeneity, using Cochran's Q statistic (n = 6), the I 2 statistic (n = 7), both Q and I 2 (n = 41), or Woolf's test (n = 2). Thirty-eight field synopses evaluated Hardy-Weinberg equilibrium using P = 0.05 as the threshold (Table 2) .
To explore potential sources of heterogeneity, the authors of 34 field synopses performed a total of 47 subgroup analyses, whereas the authors of 29 synopses performed a total of 45 sensitivity analyses. Specifically, the subgroup analyses were based on ethnicity (n = 30 synopses), disease characteristics (n = 9), and population characteristics (n = 8). Similarly, the sensitivity analyses were based on the exclusion of studies violating Hardy-Weinberg equilibrium in controls (n = 14), the exclusion of the first published study (n = 9), sample size (n = 7), study characteristics (n = 5), the exclusion of the first positive study (n = 3), or an iterative exclusion of studies (n = 7) ( Table 2 ). Five more field synopses excluded a priori all studies that were characterized by violation of Hardy-Weinberg equilibrium in the control group, as it was set by their inclusion criteria for the meta-analysis. Finally, the authors of 6 synopses performed a meta-regression to further explore potential sources of heterogeneity.
A total of 47 synopses used 1 or more methods to evaluate publication bias. Evaluation with graphical tools included funnel plots (n = 25 synopses) and Galbraith plots (n = 1). The authors of 43 synopses performed at least 1 statistical test or applied at least 1 method for the assessment of publication bias and/or small-study effects, including Egger's test (n = 30) (30), Begg's test (n = 11) (31), Harbord's test (n = 11) (32), the test for an excess of statistical significance (n = 5) (33), the fail-safe N method (n = 2) (34), or Duval and Tweedie's trim-and-fill analysis (n = 1) (35) ( Table 2) .
Reporting on the credibility of the findings and adjustment for multiple comparisons Twelve field synopses used the Venice criteria (15) to assess the epidemiologic credibility of the 449 variants included in the respective analyses, whereas 1 of them also used the Bayes factor (36) (212 variants). Only 155 of the 449 associations were found to have evidence of strong epidemiologic credibility (overall grade A) by application of the Venice criteria (15) . Eight field synopses used at least 1 method to adjust for multiple comparisons. These methods included the Bonferroni correction (n = 5 synopses; 81 assessed variants), the falsepositive report probability (37) (n = 3 synopses; 64 assessed variants), or the Bayesian false-discovery probability (38) (n = 1 synopses; 42 assessed variants).
Additionally, 3 field synopses evaluated the included studies using some quality score, including the Newcastle-Ottawa scale (n = 2) (39, 40) or other qualitative criteria defined by the research team (n = 1) (41). Moreover, 2 field synopses used the STrengthening the REporting of Genetic Association Studies (STREGA) statement, which aims to improve reporting in genetic association studies (42) (43) (44) . More details are presented in Table 2 .
Comparison of field synopses with overlapping outcomes
As we noted above, there were 18 synopses on 8 overlapping outcomes. With the exception of 2 synopses that evaluated genetic associations with ischemic stroke in South Asians and non-Europeans, all of the synopses considered participants of all ethnicities. The synopses on ischemic stroke, subarachnoid hemorrhage, meningococcal disease, and chronic obstructive pulmonary disease did not use any method to evaluate the credibility of the association or to adjust for multiple comparisons. Such tools were used in both studies on colorectal cancer, in 1 synopsis on chronic lymphocytic leukemia, and in 1 synopsis on preeclampsia. Assessment of publication bias or small-study effects was performed in most of the synopses (n = 14). In 5 of the 8 overlapping outcomes, not accounting for the 2 synopses limited to specific ethnicities, the last published synopsis did not have more eligible articles, suggesting that different search strategies and inclusion criteria may have been used. A detailed description of the synopses on overlapping outcomes is given in Appendix Table 1 .
Databases
Only 11 synopses (18%) were accompanied by online databases cataloging the findings and the studies included in the corresponding published field synopsis. In 4 databases (29, (45) (46) (47) , the authors urged interested scientists to include their data in the database by granting access through a loggingin system. The median number of authors in the field synopses supported by an online database was 12, while in field synopses without an online database the median number of authors was 4 (P = 0.02, Wilcoxon rank-sum test). Funding was associated with the existence of an online database (P = 0.046, Fisher's exact test). However, when the number of authors and the existence of funding were considered in a logistic regression model, the existence of a database was affected only by the number of authors (P = 0.007) and not by the existence of funding (P = 0.238). All tracked databases are available online and can be accessed through their initial Web address as provided by the authors. Nine of the 11 databases have been online at least 24 months, and all of them were updated at least once in the 24 months after their creation, whereas 2 databases (14, 29) have been online for less than 24 months and therefore have not been evaluated with regard to an update.
Citation analysis
Three field synopses (25, 48, 49) were published recently and have not yet been indexed in ISI Web of Science. The remaining 58 synopses have received 2,512 citations in total, with a median of 13 citations (IQR, 4-29).
Field synopses supported by an online database received a median of 21 citations, while those without a database received a median of 10 citations (P = 0.073, Wilcoxon ranksum test). However, this difference was significant when we adjusted for number of months since publication (P = 0.007) using generalized linear regression. There were no significant differences in the median journal impact factor between synopses with (7.692) and without (5.419) a database (P = 0.157). The results were similar in a sensitivity analysis where we excluded nonindexed field synopses.
DISCUSSION
To our knowledge, this is the first systematic appraisal of field synopses in genetic epidemiology summarizing the current status of the synopses published to date, along with their related online resources whenever available. We identified 61 published field synopses covering a wide spectrum of outcomes and more than 700 variants that were deemed nominally significant. However, only about one-third of those variants showed strong evidence of credibility for the respective associations whenever such criteria were applied.
The evidence of genetic associations was mostly assessed through the Venice criteria, the Bayes factor, or other statisticsbased approaches to adjustment for multiple comparisons, such as the Bonferroni correction, the Bayesian false-discovery probability, and the false-positive report probability. In most cases, the credibility of the findings was assessed and interpreted efficiently, providing information on the variants that had weak, moderate, or strong epidemiologic credibility. However, more than half of the published field synopses failed to either provide any assessment for their associations or apply a stringent P-value threshold, and therefore these findings should be interpreted with caution to avoid falsepositive inferences. At the same time, given that the stringent genome-wide significance thresholds applied in GWAS may increase the number of false-negative findings, it is important for researchers to consider the balance between false-positive and false-negative findings (50) .
Regarding dissemination of the results, we found that only about one-sixth of the synopses were supported by an online database as previously suggested (7), the presence of which improved the impact and visibility of the article. Synopses accompanied by an online database seem to attract significantly more citations than synopses without a database. All available databases have been updated and have incorporated new features for data-searching and analysis over time, improving the experience for the involved investigators and clinicians and promoting the relevant scientific fields.
As expected, all field synopses used meta-analytical techniques to synthesize available evidence. Meta-analysis is now a sine qua non for the discovery of common variants for complex diseases (51); it is especially valuable when applied to studies retrieved through systematic literature reviews, such as those typically performed in field synopses. In this context, meta-analytical techniques and related "diagnostic" procedures can help identify biases (e.g., small-study effects, excess significance bias, and other types of bias) and assess between-study heterogeneity and its potential sources, and in general they provide insights about the validity of the proposed associations. Overall, the current findings support the crucial role of meta-analysis in the discovery of novel genetic associations either through synthesis of published studies or through meta-analysis of individual-level data as routinely performed in GWAS consortia (52) .
Our study has some caveats that should be acknowledged. First, we did not include synopses focusing on gene families, gene pathways (53) , or multiple variants of a specific gene (54) , even though such approaches may have been conducted rigorously. In addition, we did not include databases that were not accompanied by published articles describing the results in detail or a published article focusing on technical characteristics, such as MSGene (http://www.msgene.org/), ALSGene (55), or CADgene (56) . These initiatives are expected to follow stringent criteria for the synthesis and reporting of the available data, and they add to the existing evidence of genetic associations. Such efforts should be encouraged and should follow the proper guidelines as previously reported (7, 15, 44) . Furthermore, some investigators have systematically appraised the published meta-analyses of genetic association studies related to a specific disease. For example, in an overview of meta-analyses, Dong et al. (57) examined the validity of genetic associations for cancer, estimating the false-positive report probability. This methodology did not provide a complete snapshot of all published genetic associations related to cancer susceptibility, but it contributed to the identification of false-positive genetic associations. Moreover, we did not capture articles published before 2007, given that the actual definition of a field synopsis and the ideal description of a field synopsis had not been set by that time. Finally, we stress that our work summarizes and provides a snapshot of the field without assessing the methodological approaches used by the synopses' authors. Of course, all of the approaches may have certain disadvantages, and it is possible that in some cases they may have been used inappropriately.
Field synopses have been proven to be a valuable tool for identifying common variants in the past, and we expect that new findings will be continuously added in the future. This method could also be proven useful for rare variants, where single studies will mostly lack the statistical power to show a significant association. Therefore, it is obvious that the rapid evolution of the field necessitates such systematic approaches for the quantitative synthesis and critical appraisal of significant associations. However, researchers should adhere to rules and guidelines, such as those provided by the HuGENet road map (7), in order to achieve adequate quality and reporting of the identified signals. Similar approaches, such as umbrella reviews, are already being used in other fields of epidemiology to systematically appraise the validity and credibility of different factors, including biomarkers or other environmental risk factors (58) . The existence of an online database and the application of statistical approaches to evaluate the cumulative evidence and to adjust for multiple comparisons may improve the reporting and impact of field synopses.
